Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... HIV protease inhibitors with ritonavir to increase the blood levels of these antiretroviral drugs prescribed to treat HIV infection. However, significant complications are ... inhibitors. Our goal is to provide patients with a potent and well-tolerated once-daily therapy without the side effects, inconvenience and expense of an additional drug." ...
2009 NOV 23 ... (HIV) infection is well documented, especially with regard to adherence to highly active antiretroviral therapy (HAART). We used the data from a 5-year longitudinal study of the MANIF 2000 cohort of ...
2009 NOV 23 ... by stimulation with HIV-1 peptide-loaded DC derived from HIV-1-infected subjects on antiretroviral therapy. We first found that mature DC increased the number of gamma interferon ...
2009 NOV 23 ... a study from Bulawayo, Zimbabwe, "An HIV/AIDS and TB coinfection model which considers antiretroviral therapy for the AIDS cases and treatment of all forms of TB, i.e., latent and active forms of ...
2009 NOV 23 ... CD1 and CD2) with expert opinion in a prospective cohort of patients who were starting antiretroviral therapy in South Africa." "A total of 498 adult patients were monitored for the ...
2009 NOV 23 ... company with operations in several African countries was committed to offer antiretroviral treatment to its employees and their dependants. Approach The Accelerating Access ... Syndrome, Antivirals, HIV, Human Immunodeficiency Virus, Pharmaceuticals, Therapy, Treatment, Virology. This article was prepared by Anti-Infectives Week ...
2009 NOV 23 ... between HIV stigma and: self-reported access to care, regular source of HIV care, and antiretroviral therapy adherence; and to test whether mental health mediates these associations. ...
2009 NOV 23 ... to treat, given the propensity for drug interactions between the rifamycins and the antiretroviral drugs. We examined the pharmacokinetics of rifabutin before and after the addition of ... Protease Inhibitor, Rifabutin, Ritonavir, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology, University of Florida. This article was ...
2009 NOV 17 ... access to health care on a national scale. Today, one in three people with HIV taking antiretroviral therapy receive services at a facility that has benefited from Abbott Fund support. ...
2009 NOV 23 ... pregnant women, which is essential in order to be able to test mothers for HIV and begin antiretroviral therapy that can cut the risk of mother-to-child transmission to virtually zero. Even before ...
2009 NOV 23 ... began an 8 day exposure to maraviroc (MCT group); six HIV-infected patients without antiretroviral therapy received no treatment (control group). Plasma viral load was evaluated on days 0, 2, 5 ...
2009 NOV 23 ... "Patients infected with Human immunodeficiency virus (HIV) living longer with antiretroviral therapy (ART) are more likely to develop non-AIDS-defining cancers such as adenocarcinoma of the ...
2009 NOV 23 ... active drugs in human immunodeficiency virus (HIV)-infected patients receiving failing antiretroviral therapy is a key determinant of subsequent treatment efficacy. The aim of this study was to ...
2009 NOV 23 ... to achieve high CD4 cell counts while receiving virally suppressive highly active antiretroviral therapy (HAART) are uncertain. We analysed data from HIV-infected men participating in the ...
2009 NOV 16 ... immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a major target for antiretroviral strategy to block or curtail HIV infection. A suitable RT-SHIV/macaque model is urgently ... Immunology, Proteins, Proteomics, Reverse Transcriptase, Sexually Transmitted Disease, Therapy, Transcriptase, Treatment, Viral, Virology, University of Washington. This ...
2009 NOV 16 ... knowledge on the antiviral efficacy, dosing, and toxicity of available highly active antiretroviral therapy regimens is mostly derived from plasma or blood kinetics of anti-human immunodeficiency ...
2009 NOV 16 ... the United Kingdom, "Mechanisms underlying the lipodystrophy syndrome associated with antiretroviral therapy (ART) for HIV infection are not completely understood. We investigated the effect of ART ...
2009 NOV 23 ... human immunodeficiency virus (HIV)-infected patients after the introduction of combined antiretroviral therapy, pulmonary arterial hypertension (PAH) has become an important cause of morbidity. As ...
2009 NOV 16 ... and is renally excreted with minimal to no hepatic metabolism. It has demonstrated antiretroviral activity against drug-resistant strains both in vitro and in vivo. In clinical studies, ... Pharmacokinetics, Pharmacology, Pharmacotherapy, Prodrug, Regulatory Actions, Therapy, Treatment, Virology. This article was prepared by AIDS Weekly editors from ...
2009 NOV 16 ... PCR. The HBV genotype was determined in 20 cases with occult HBV infection. Data on the antiretroviral therapy (ART) regimen was obtained in 169 individuals: 53 (31.4%) patients were ART-naive, 46 ...
